
A bench comprising judicial member Ravish Sood and accountant member G Manjunatha ruled that a Central Board of Direct Taxes circular and the IMC’s regulations could not be relied upon to disallow a drug company’s expenditure claims. The IMC’s code of conduct applies only to medical practitioners and doctors and not to pharmaceutical companies and the healthcare sector, it said.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/311nWZf
via
IFTTT
0 comments:
Post a Comment